Fritextsökning
Innehållstyper
-
ZEISS Quality Innovations at CONTROL
May 6-9, 2025 in Stuttgart.
-
She is CSL Behring's new Nordic General Manager
Since the beginning of january, Helena Bragd is the new Nordic General Manager for the biotech company CSL Behring and CEO of CSL Behring AB.
-
Scientific Solutions och Reveal stärker sitt samarbete
Scientific Solutions och Reveal tillhör sedan ett par år tillbaka samma företagsgrupp och har i flera samarbeten stöttat sina kunder inom Life Science-sektorn. ...
-
KI-forskare har upptäckt biomarkörer för postcovid
Forskare vid Karolinska institutet har i en ny studie identifierat en uppsättning proteiner i blod hos personer med långvariga besvär av postcovid.
-
AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence
AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.
-
Lilly recruits top Swedish researcher in Alzheimer´s
One of Sweden's leading Alzheimer's researchers, Oskar Hansson, has been recruited by pharma giant Eli Lilly and will be moving to the USA.
-
High-performance Slide Scanner for Fluorescence, Brightfield and Polarization
ZEISS Axioscan 7.
-
Lonza
-
Fundamental Aspects of Airy Disk Patterns
Knowledge Article from ZEISS.
-
SGS Fimko Ltd.
-
Business Sweden: “Companies have a lot to offer in data-driven precision medicine”
Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.
-
Mavatar AB
-
Faster development of reliable sample handling
Festo USA has collaborated with PerkinElmer to develop a compact sample handling solution for a global leader in manufacturing medical devices. Thanks to the cu...
-
Failed to read the fine print – lost his life’s work
A celebrated CEO and co-founder of a pioneering lab company one moment – the next, fired, kicked out and written out of the company’s history. This is the story...
-
Mångmiljardaffär i jakten på nästa blockbuster inom cancer
Bristol Myers Squibb betalar upp till 11,1 miljarder dollar, motsvarande 106 miljarder kronor, för att köpa in sig i en av de hetaste läkemedelskandidaterna inom immunonkologi.
-
RegSmart Life Science AB
-
Wusson Accelerator AB
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...
-
Truly Labs AB
-
Speed meets precision for high-density components
ZEISS METROTOM 800 320 kV.
-
”Scientific Solutions är sina anställda”
I år firar Scientific Solutions 15 år! Företagets VD Henrik Södermark har fått svara på några frågor om dåtid, nutid och framtid och avslöjar bland annat vilken...
-
Webinar: Support Trial Patients Transitioning to the Commercial Space
Register for expert insights on supporting Phase III clinical trial patients post-approval and read our blog on advanced Patient Assistance Programs.
-
Anna Törner: To kill your darlings
Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...
-
Microscopy in Urinalysis: Observe Urine, Detect Abnormalities
Webinar on 18th March 2025, 10 AM - 11 AM CET.